The U.S. stock market is poised to be kept on edge next year as investors are caught between fear of missing out on the artificial-intelligence rally and concern that it’s a bubble just waiting to ...

No matter how much investors hope it will happen, volatility in the stock market isn’t going away, and market swings of a few ...

It’s been a strong year for stocks and investors look set to carry that bullish mood into 2026, with the consensus view that more gains lie in store. Positioning in equities is rising and fund ...

When markets get ugly, the difference between investors who survive and those who thrive usually comes down to a handful of ...

The VanEck Pharmaceutical ETF offers concentrated exposure to large-cap global pharma leaders, balancing growth, defensive, and non-drug cash flow stabilizers. PPH has demonstrated resilience, ...

CHONGQING, CHINA - SEPTEMBER 28: In this photo illustration, a hand holds a smartphone displaying the logo of Tilray Brands, Inc. (NASDAQ: TLRY), the American-Canadian pharmaceutical and ...

Wall Street is not whispering about 2026, it is broadcasting a clear message: the base case is another year of gains for U.S.

Since spot Bitcoin ETFs launched in 2024, aggregate U.S. spot BTC products have at times bought more than twice the daily newly issued Bitcoin, steadily absorbing free float. One flagship Bitcoin ...

AOR holds 60% stocks and 40% bonds with automatic rebalancing at a 0.15% expense ratio. The fund returned 14% in 2025 and averaged 8% annually over the past decade. AOK offers a more conservative ...